Company profit and survival drives pharmaceutical pricing

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.341, 2001-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prospective of Pricing in Pharmaceutical Environment

Applied Clinical Research, Clinical Trials and Regulatory Affairs, Vol. 1, Iss. 3, 2014-01 ,pp. : 151-156

Bentham Science Publishers

Access to resources Recommend Favorite

A Footnote on Pharmaceutical Pricing

By Smith Mickey C.

Journal of Pharmaceutical Marketing & Management, Vol. 18, Iss. 1, 2008-01 ,pp. : 107-114

Haworth Press

Access to resources Recommend Favorite

Consumers' role in pharmaceutical pricing decisions

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 359, 2002-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Effects of Reference Pricing in Pharmaceutical Markets: A Review

By >

PharmacoEconomics, Vol. 29, Iss. 1, 2011-01 ,pp. : 17-33

Adis International

Access to resources Recommend Favorite

Comparative Effectiveness Research: The View from a Pharmaceutical Company

By Berger Marc L. Grainger David

PharmacoEconomics, Vol. 28, Iss. 10, 2010-10 ,pp. : 915-922

Adis International

Access to resources Recommend Favorite